Hutchison Chi-Med to trial HMPL-689 in China
HUTCHMED (China) Limited
324.00p
08:59 07/10/24
4.52%
14.00p
Hutchison China MediTech announced on Tuesday that it has initiated a Phase I clinical trial of HMPL‑689 in China.
FTSE AIM 100
3,593.86
09:00 07/10/24
n/a
n/a
FTSE AIM All-Share
738.96
09:00 07/10/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,093.96
09:00 07/10/24
-0.06%
-14.28